Answer
Agomelatine (Valdoxan) is preferably avoided during pregnancy as a precaution because human data are absent or limited to fewer than 300 pregnancy outcomes, although animal studies do not indicate harmful reproductive or developmental effects.
Sources for this answer
- ValdoxanServier Laboratories Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked